In humanized mice transplanted with either CD4+ T cells or CD34+ HSC, ZFN-mediated CCR5 disruption has been shown to confer resistance to de novo infection by CCR5-tropic HIV-1, thereby controlling virus replication [49], [50]. Here, CCR5 is linked to infection.